title: Chlorambucil - rituximab as first line combination therapy in follicular non-Hodgkin's lymphoma: a clinical and biological analysis.
authors.forename: D
authors.initials: D
authors.lastname: Laszlo
authors.forename: C
authors.initials: C
authors.lastname: Rabascio
authors.forename: G
authors.initials: G
authors.lastname: Andreola
authors.forename: G
authors.initials: G
authors.lastname: Pruneri
authors.forename: V
authors.initials: V
authors.lastname: Raia
authors.forename: L
authors.initials: L
authors.lastname: Calabrese
authors.forename: D
authors.initials: D
authors.lastname: Radice
authors.forename: L
authors.initials: L
authors.lastname: Saronni
authors.forename: G
authors.initials: G
authors.lastname: Martinelli
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000276:immunology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002699:Chlorambucil / Q000008:administration & dosage; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D008224:Lymphoma, Follicular / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D002699:Chlorambucil; D000069283:Rituximab